Lorenzo et al. (2021) in their in situ analysis confirmed the presence of DCLK1 only in tumor tissues. Furthermore, in CAA cells, inhibition of CD133+ and LGR5+ cell cultures (Lorenzo et al., 2021) exerted non-malignant consequences in primary cultures. The gene discussed is DCLK1; the disease is neoplasm.